About this trial
This pilot study will have patients use a smart sharps disposal container at home for disposal of needles used to administer their hemophilia drugs. The study aims to find out if the smart sharps container proved acceptable to use by patients and medical providers and can be adhered to.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Male or female, ≥18 years of age
Moderate or Severe Hemophilia A or B, with or without an inhibitor
Prescribed prophylaxis with either a factor product or emicizumab that is scheduled to be given at least once every 14 days
Stated inability to use the SharpsCue container
Disqualifiers
None
Trial design
Single group
Treatments tested in this trial
The smart Sharps device is given to the patient and they use it to throw needles away in. It is not internal to the patient.
Other interventionThe smart Sharps device is given to the patient and they use it to throw needles away in. It is not internal to the patient.
Treatment groups
Trial outcomes
Primary outcomes
Adherence
% from baseline to active phase that patient adheres to using needle disposal
Secondary outcomes
Patient and provider satisfaction survey
Patient and provider satisfaction survey
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Pennsylvania
Lead sponsor
Sharpscue
Collaborator
This trial is not recruiting at the moment. You can still explore other options: